The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
暂无分享,去创建一个
[1] R. Rahman,et al. Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management: A meta-analysis , 2017, Journal of telemedicine and telecare.
[2] L. Ferreira,et al. Diaphragm abnormalities in heart failure and aging: mechanisms and integration of cardiovascular and respiratory pathophysiology , 2017, Heart Failure Reviews.
[3] J. Cleland,et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure , 2016, Heart.
[4] J. Butler,et al. Depression in heart failure: Can PHQ-9 help? , 2016, International journal of cardiology.
[5] Rod S Taylor,et al. Home-based cardiac rehabilitation for people with heart failure: A systematic review and meta-analysis. , 2016, International journal of cardiology.
[6] N. Smart,et al. The effect of resistance training on clinical outcomes in heart failure: A systematic review and meta-analysis. , 2016, International journal of cardiology.
[7] P. Ponikowski,et al. [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.
[8] K. Kemper,et al. Integrative Medical Care Plus Mindfulness Training for Patients With Congestive Heart Failure , 2016, Journal of evidence-based complementary & alternative medicine.
[9] G. Tomlinson,et al. Mechanisms of Chronic Muscle Wasting and Dysfunction after an Intensive Care Unit Stay. A Pilot Study. , 2016, American journal of respiratory and critical care medicine.
[10] K. Anstrom,et al. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. , 2016, JAMA.
[11] S. Lipsitz,et al. Quality of End-of-Life Care Provided to Patients With Different Serious Illnesses. , 2016, JAMA internal medicine.
[12] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[13] E. Hui,et al. Symptom clusters and quality of life among patients with advanced heart failure , 2016, Journal of geriatric cardiology : JGC.
[14] J. Semmens,et al. A retrospective population based cohort study of access to specialist palliative care in the last year of life: who is still missing out a decade on? , 2016, BMC Palliative Care.
[15] Jeroen J. Bax,et al. Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency , 2016, European journal of heart failure.
[16] M. Cowie,et al. Sleep‐disordered breathing in heart failure , 2016, European journal of heart failure.
[17] A. Strömberg,et al. An integrated review of interventions to improve psychological outcomes in caregivers of patients with heart failure , 2016, Current opinion in supportive and palliative care.
[18] J. Denollet,et al. Antidepressant use and risk for mortality in 121,252 heart failure patients with or without a diagnosis of clinical depression. , 2016, International journal of cardiology.
[19] R. Rahman,et al. Aberystwyth University Quality of life in patients receiving telemedicine enhanced chronic heart failure disease management , 2016 .
[20] R. Carney,et al. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial. , 2015, JAMA internal medicine.
[21] Patrick Levy,et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. , 2015, The New England journal of medicine.
[22] P. Ponikowski,et al. Phrenic nerve stimulation for the treatment of central sleep apnea. , 2015, JACC. Heart failure.
[23] Y. Kihara,et al. Adaptive servo-ventilation therapy for patients with chronic heart failure in a confirmatory, multicenter, randomized, controlled study. , 2015, Circulation journal : official journal of the Japanese Circulation Society.
[24] Miriam J. Johnson,et al. Palliative Care among Heart Failure Patients in Primary Care: A Comparison to Cancer Patients Using English Family Practice Data , 2014, PloS one.
[25] P. Kirchhof,et al. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. , 2014, European heart journal.
[26] H. Ulmer,et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a multicentre randomized trial , 2014, European journal of heart failure.
[27] A. Parkhomenko,et al. Repetitive use of levosimendan for treatment of chronic advanced heart failure: clinical evidence, practical considerations, and perspectives: an expert panel consensus. , 2014, International journal of cardiology.
[28] C. Gamel,et al. Sexuality of patients with chronic heart failure and their spouses and the need for information regarding sexuality , 2014, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[29] F. Fedele,et al. Heart failure: TNM-like classification. , 2014, Journal of the American College of Cardiology.
[30] P. Ponikowski,et al. Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial , 2013, European heart journal.
[31] A. Zangrillo,et al. Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials , 2014, Clinical Research in Cardiology.
[32] B. Fridlund,et al. Sexual counselling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). , 2013, European heart journal.
[33] B. Fridlund,et al. Sexual counseling for individuals with cardiovascular disease and their partners: a consensus document from the American Heart Association and the ESC Council on Cardiovascular Nursing and Allied Professions (CCNAP). , 2013, Circulation.
[34] K. Vermeulen,et al. Preferences of heart failure patients in daily clinical practice: quality of life or longevity? , 2013, European journal of heart failure.
[35] M. de Antonio,et al. Depression, antidepressants, and long-term mortality in heart failure. , 2013, International journal of cardiology.
[36] A. Parkhomenko,et al. Renal Effects of Levosimendan: A Consensus Report , 2013, Cardiovascular Drugs and Therapy.
[37] B. Massie,et al. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. , 2013, JACC. Heart failure.
[38] Theresa M Beckie,et al. Council on cardiovascular and stroke nursing. , 2013, The Journal of cardiovascular nursing.
[39] Piotr Ponikowski,et al. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial , 2013, The Lancet.
[40] A. Parkhomenko,et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. , 2012, International journal of cardiology.
[41] G. Bellomo,et al. Levosimendan Protection against Kidney Ischemia/Reperfusion Injuries in Anesthetized Pigs , 2012, Journal of Pharmacology and Experimental Therapeutics.
[42] R. Taniguchi,et al. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure. , 2012, Journal of cardiology.
[43] A. Delaney,et al. Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials , 2012, Intensive Care Medicine.
[44] Kari A Carter,et al. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. , 2011, Mayo Clinic proceedings.
[45] A. Laska,et al. Quality of life in chronic disease: a comparison between patients with heart failure and patients with aphasia after stroke. , 2010, Journal of clinical nursing.
[46] D. Horstkotte,et al. Sleep‐disordered breathing in heart failure with normal left ventricular ejection fraction , 2009, European journal of heart failure.
[47] P. Ponikowski,et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology , 2009, European journal of heart failure.
[48] C. O’loughlin,et al. A comparative study of the palliative care needs of heart failure and cancer patients , 2009, European journal of heart failure.
[49] D. Moser,et al. Quality of life in patients with heart failure: ask the patients. , 2009, Heart & lung : the journal of critical care.
[50] R. Califf,et al. Changing preferences for survival after hospitalization with advanced heart failure. , 2008, Journal of the American College of Cardiology.
[51] R. Califf,et al. Antidepressant use, depression, and survival in patients with heart failure. , 2008, Archives of internal medicine.
[52] Heather J Ross,et al. Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[53] N. Punjabi. The epidemiology of adult obstructive sleep apnea. , 2008, Proceedings of the American Thoracic Society.
[54] S. Mavrogeni,et al. A 6-month follow-up of intermittent levosimendan administration effect on systolic function, specific activity questionnaire, and arrhythmia in advanced heart failure. , 2007, Journal of cardiac failure.
[55] Michael Böhm,et al. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology , 2007, European journal of heart failure.
[56] A. Cohen-Solal,et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.
[57] C. Yancy,et al. The Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial for advanced heart failure: study rationale and design. , 2007, American heart journal.
[58] P. Seferovic,et al. Haemodynamic and clinical effects of ularitide in decompensated heart failure. , 2006, European heart journal.
[59] G. Tomlinson,et al. Continuous positive airway pressure for central sleep apnea and heart failure. , 2005, The New England journal of medicine.
[60] C. Yancy,et al. Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial). , 2004, The American journal of cardiology.
[61] M. Nieminen,et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.
[62] B. Massie,et al. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. , 1993, Journal of the American College of Cardiology.
[63] Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. , 1993, Journal of the American College of Cardiology.
[64] D. DeMets,et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.